抗がん薬物療法前のHBVマーカー測定は教育的介入で改善するか？―左室機能検査実施率との比較を含めた後方視的検討―

概要

論文の詳細を見る
Hepatitis B virus (HBV) reactivation is a complication of chemotherapy. But the frequency of testing for HBV before chemotherapy was low. An educational intervention was delivered to the oncology team. Of 98 new patients who received chemotherapy, 24.5% underwent HBsAb or anti-HBcAb screening before chemotherapy. But 89.2% of 65 patients who received cardiotoxic chemotherapy underwent LVF test. After educational intervention, the frequency of HBV testing increased to 76.8% of 155 patients received chemotharapy, but still fell short of LVF testing. An intervention resulted a modest improvement. To increase the frequency of HBV screening before chemotharapy, we feel that additional education of HBV reativation in solid tumor.